Summa Equity is an impact investment firm focusing on Resource Efficiency, Changing Demographics, and Tech-Enabled Transformation. The company invests in innovative solutions for a sustainable future, targeting industries influenced by global megatrends. Founded in 2016, Summa Equity manages approximately EUR 5 billion in assets.
- Biopharmaceuticals
- Manufacturing
- Pharmaceuticals
- Biotechnology
- Aquaculture
- Animal Health
- Cybersecurity
- It Infrastructure Security
- Digital Transformation
- Sustainability
Leadership
| Name | Title | ||
|---|---|---|---|
| Sercan Samanci | Investment Manager |
in/sercan-samanci-37684a70
|
|
| Investment Director |
|
|
|
| Investment Manager |
|
|
|
| Investment Director |
|
|
|
| Founder & Managing Partner |
|
|
|
| Investment Manager |
|
|
|
| Investment Manager |
|
|
Recent Transactions involving Summa Equity
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Summa Equity owned myneva Group continues its growth journey with the acquisition of DM EDV |
DM EDV |
myneva |
Summa Equity |
Healthcare Software |
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →